Wondergem M - Search Results

1

The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.

Hagens MJ, Luining WI, Jager A, Donswijk ML, Cheung Z, Wondergem M, Oprea-Lager DE, Vis AN, van Leeuwen PJ, van der Poel HG. Hagens MJ, et al. Among authors: wondergem m. J Nucl Med. 2023 Aug;64(8):1238-1243. doi: 10.2967/jnumed.122.265205. Epub 2023 Jun 29. J Nucl Med. 2023. PMID: 37385673

2

Ruling out coronary artery disease in women with atypical chest pain: results of calcium score combined with coronary computed tomography angiography and associated radiation exposure.

van der Zant FM, Wondergem M, Lazarenko SV, Geenen RW, Umans VA, Cornel JH, Knol RJ. van der Zant FM, et al. Among authors: wondergem m. J Womens Health (Larchmt). 2015 Jul;24(7):550-6. doi: 10.1089/jwh.2014.4929. Epub 2015 Apr 8. J Womens Health (Larchmt). 2015. PMID: 25853801

3

Authors' Response to Vadvala, et al.

Knol RJ, Wondergem M, van der Zant FM. Knol RJ, et al. Among authors: wondergem m. J Womens Health (Larchmt). 2015 Dec;24(12):1051. doi: 10.1089/jwh.2015.29003.rkr. J Womens Health (Larchmt). 2015. PMID: 26653870 No abstract available.

4

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.

Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG. Wondergem M, et al. J Nucl Med. 2013 Aug;54(8):1294-301. doi: 10.2967/jnumed.112.117614. Epub 2013 Jun 7. J Nucl Med. 2013. PMID: 23749996 Free article.

5

¹⁸F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.

Wondergem M, van der Zant FM, Knol RJJ, Lazarenko SV, Pruim J, de Jong IJ. Wondergem M, et al. J Nucl Med. 2017 Nov;58(11):1797-1804. doi: 10.2967/jnumed.117.192658. Epub 2017 Apr 27. J Nucl Med. 2017. PMID: 28450569 Free article.

6

Effects of Fasting on ¹⁸F-DCFPyL Uptake in Prostate Cancer Lesions and Tissues with Known High Physiologic Uptake.

Wondergem M, van der Zant FM, Vlottes PW, Knol RJJ. Wondergem M, et al. J Nucl Med. 2018 Jul;59(7):1081-1084. doi: 10.2967/jnumed.117.207316. Epub 2018 Mar 1. J Nucl Med. 2018. PMID: 29496983 Free article. Clinical Trial.

7

Dual-Time-Point ¹⁸F-Fluorocholine PET/CT in Parathyroid Imaging.

Broos WAM, Wondergem M, van der Zant FM, Knol RJJ. Broos WAM, et al. Among authors: wondergem m. J Nucl Med. 2019 Nov;60(11):1605-1610. doi: 10.2967/jnumed.118.225599. Epub 2019 Mar 15. J Nucl Med. 2019. PMID: 30877179 Free article.

8

Increased PSMA Expression in Castration-Resistant Prostate Cancer Metastases 3 Months After Initiation of Enzalutamide Indicated by 18F-DCFPyL PET/CT.

Wondergem M, van der Zant F, Broos W, Knol R. Wondergem M, et al. Clin Nucl Med. 2019 Jul;44(7):582-584. doi: 10.1097/RLU.0000000000002585. Clin Nucl Med. 2019. PMID: 31058686

9

Early lesion detection with ¹⁸F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer.

Wondergem M, Jansen BHE, van der Zant FM, van der Sluis TM, Knol RJJ, van Kalmthout LWM, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN. Wondergem M, et al. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1911-1918. doi: 10.1007/s00259-019-04385-6. Epub 2019 Jun 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31230088 Free PMC article.

10

18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer.

Meijer D, Wondergem M, Knol RJJ, Broos WAM, van der Zant FM. Meijer D, et al. Among authors: wondergem m. Clin Nucl Med. 2020 Feb;45(2):e96-e97. doi: 10.1097/RLU.0000000000002738. Clin Nucl Med. 2020. PMID: 31361646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page